{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:14:32Z","timestamp":1778876072440,"version":"3.51.4"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010296","name":"James B. Pendleton Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006967","name":"CFAR","doi-asserted-by":"publisher","award":["CFAR P30 AI064518"],"award-info":[{"award-number":["CFAR P30 AI064518"]}],"id":[{"id":"10.13039\/100006967","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI069511"],"award-info":[{"award-number":["UM1 AI069511"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI068614"],"award-info":[{"award-number":["UM1 AI068614"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI068635"],"award-info":[{"award-number":["UM1 AI068635"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000993","name":"Battelle","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000952","name":"Paul G. Allen Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE027245"],"award-info":[{"award-number":["R01DE027245"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ebiom.2022.104271","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T08:32:58Z","timestamp":1664267578000},"page":"104271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens"],"prefix":"10.1016","volume":"84","author":[{"given":"Yunda","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-3270","authenticated-orcid":false,"given":"Kelly E.","family":"Seaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3401-5935","authenticated-orcid":false,"given":"Jack","family":"Heptinstall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0333-5925","authenticated-orcid":false,"given":"Lindsay N.","family":"Carpp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2652-3734","authenticated-orcid":false,"given":"April Kaur","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyle R.","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna","family":"Viegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda E.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan P.","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srilatha","family":"Edupuganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Keefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina C.","family":"Hosseinipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Goepfert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen W.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-548X","authenticated-orcid":false,"given":"Brian D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juilee","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-0272","authenticated-orcid":false,"given":"James J.","family":"Kobie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2022.104271_bib0001","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104271_bib0002","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104271_bib0003","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.it.2020.04.001","article-title":"Improving vaccine-induced immunity: can baseline predict outcome?","volume":"41","author":"Tsang","year":"2020","journal-title":"Trends in Immunology"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104271_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006601","article-title":"Heterogeneity and longevity of antibody memory to viruses and vaccines","volume":"16","author":"Antia","year":"2018","journal-title":"PLoS Biol"},{"issue":"25","key":"10.1016\/j.ebiom.2022.104271_bib0005","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104271_bib0006","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/infdis\/jiq156","article-title":"Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans","volume":"203","author":"Bucasas","year":"2011","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104271_bib0007","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/infdis\/jix609","article-title":"Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America","volume":"217","author":"Moodie","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226803","article-title":"Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans","volume":"15","author":"Zhao","year":"2020","journal-title":"Plos One"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104271_bib0009","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.vaccine.2019.10.046","article-title":"Updates on immunologic correlates of vaccine-induced protection","volume":"38","author":"Plotkin","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104271_bib0010","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104271_bib0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"268","key":"10.1016\/j.ebiom.2022.104271_bib0012","doi-asserted-by":"crossref","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104271_bib0013","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1073\/pnas.1519690113","article-title":"Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood","volume":"113","author":"Nakaya","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104271_bib0014","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/cid\/ciz1034","article-title":"Comparative immunogenicity of several enhanced influenza vaccine options for older adults: a randomized, controlled trial","volume":"71","author":"Cowling","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104271_bib0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/21645515.2019.1680082","article-title":"High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy","volume":"16","author":"Grazzini","year":"2020","journal-title":"Hum Vacc Immunother"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","article-title":"Primary vaccine failure to routine vaccines: why and what to do?","volume":"12","author":"Wiedermann","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104271_bib0017","first-page":"106","article-title":"Non-responders to hepatitis B vaccination: a review","volume":"6","author":"Kubba","year":"2003","journal-title":"Commun Dis Public Health"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104271_bib0018","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41591-020-0769-8","article-title":"Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus","volume":"26","author":"Kotliarov","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0019","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1186\/s12879-020-05634-y","article-title":"A simple clinical score to identify likely hepatitis B vaccination non-responders - data from a retrospective single center study","volume":"20","author":"Meier","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104271_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-018-0103-6","article-title":"Advancing an HIV vaccine; advancing vaccinology","volume":"19","author":"Burton","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104271_bib0021","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/COH.0000000000000362","article-title":"Lessons learned from human HIV vaccine trials","volume":"12","author":"Pollara","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"issue":"516","key":"10.1016\/j.ebiom.2022.104271_bib0022","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz2686","article-title":"Multiple roles for HIV broadly neutralizing antibodies","volume":"11","author":"Haynes","year":"2019","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104271_bib0023","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"Flynn","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104271_bib0024","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand","volume":"194","author":"Pitisuttithum","year":"2006","journal-title":"J Infect Dis"},{"issue":"9653","key":"10.1016\/j.ebiom.2022.104271_bib0025","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104271_bib0026","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"10.1016\/j.ebiom.2022.104271_bib0027","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ebiom.2022.104271_bib0028","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104271_bib0029","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","article-title":"Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120-MF59 in adults","volume":"384","author":"Gray","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104271_bib0030","series-title":"Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa","year":"2021"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0031","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imr.12514","article-title":"Complex immune correlates of protection in HIV-1 vaccine efficacy trials","volume":"275","author":"Tomaras","year":"2017","journal-title":"Immunol Rev"},{"issue":"14","key":"10.1016\/j.ebiom.2022.104271_bib0032","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104271_bib0033","doi-asserted-by":"crossref","first-page":"e87572","DOI":"10.1371\/journal.pone.0087572","article-title":"Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection","volume":"9","author":"Zolla-Pazner","year":"2014","journal-title":"Plos One"},{"issue":"22","key":"10.1016\/j.ebiom.2022.104271_bib0034","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104271_bib0035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104271_bib0036","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"Lin","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"228","key":"10.1016\/j.ebiom.2022.104271_bib0037","doi-asserted-by":"crossref","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci Transl Med"},{"issue":"15","key":"10.1016\/j.ebiom.2022.104271_bib0038","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1128\/JVI.01164-14","article-title":"Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial","volume":"88","author":"Gartland","year":"2014","journal-title":"J Virol"},{"issue":"296","key":"10.1016\/j.ebiom.2022.104271_bib0039","doi-asserted-by":"crossref","first-page":"296ra112","DOI":"10.1126\/scitranslmed.aab4005","article-title":"HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition","volume":"7","author":"Prentice","year":"2015","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104271_bib0040","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1172\/JCI75539","article-title":"FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial","volume":"124","author":"Li","year":"2014","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104271_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003404","article-title":"HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1","volume":"9","author":"Hertz","year":"2013","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104271_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103446","article-title":"Predictors of HVTN 503 MRK-AD5 HIV-1 GAG\/POL\/NEF vaccine induced immune responses","volume":"9","author":"Hopkins","year":"2014","journal-title":"Plos One"},{"issue":"20","key":"10.1016\/j.ebiom.2022.104271_bib0043","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.vaccine.2015.03.036","article-title":"Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials","volume":"33","author":"Jin","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104271_bib0044","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.vaccine.2016.09.053","article-title":"Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials","volume":"35","author":"Huang","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104271_bib0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CVI.00717-15","article-title":"Subtype C gp140 vaccine boosts immune responses primed by the South African AIDS vaccine initiative DNA-C2 and MVA-C HIV vaccines after more than a 2-year gap","volume":"23","author":"Gray","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104271_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161753","article-title":"Sequential immunization with gp140 boosts immune responses primed by modified vaccinia ankara or DNA in HIV-Uninfected South African participants","volume":"11","author":"Churchyard","year":"2016","journal-title":"Plos One"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104271_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179597","article-title":"Immunogenicity of a novel Clade B HIV-1 vaccine combination: results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults","volume":"12","author":"Buchbinder","year":"2017","journal-title":"Plos One"},{"issue":"510","key":"10.1016\/j.ebiom.2022.104271_bib0048","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax1880","article-title":"Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa","volume":"11","author":"Gray","year":"2019","journal-title":"Sci Transl Med"},{"issue":"13","key":"10.1016\/j.ebiom.2022.104271_bib0049","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137079","article-title":"Robust antibody and cellular responses induced by DNA-only vaccination for HIV","volume":"5","author":"De Rosa","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104271_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003038","article-title":"Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120\/MF59 vaccines","volume":"17","author":"Laher","year":"2020","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104271_bib0051","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1172\/JCI128699","article-title":"DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial","volume":"129","author":"Rouphael","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0052","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/cid\/ciz1239","article-title":"Phase 1 Human Immunodeficiency Virus (HIV) vaccine trial to evaluate the safety and immunogenicity of HIV Subtype C DNA and MF59-adjuvanted subtype C envelope protein","volume":"72","author":"Hosseinipour","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0053","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/infdis\/jiu003","article-title":"Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","volume":"210","author":"Goepfert","year":"2014","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.ebiom.2022.104271_bib0054","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","article-title":"Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","volume":"323","author":"Horton","year":"2007","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104271_bib0056","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ymeth.2012.01.001","article-title":"Vaccine applications of flow cytometry","volume":"57","author":"De Rosa","year":"2012","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104271_bib0057","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cyto.a.22590","article-title":"OMIP-025: evaluation of human T- and NK-cell responses including memory and follicular helper phenotype by intracellular cytokine staining","volume":"87","author":"Moncunill","year":"2015","journal-title":"Cytometry A"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104271_bib0058","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/cyto.a.22218","article-title":"OMIP-014: validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining","volume":"81","author":"De Rosa","year":"2012","journal-title":"Cytometry A"},{"issue":"9653","key":"10.1016\/j.ebiom.2022.104271_bib0059","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0060","doi-asserted-by":"crossref","first-page":"13031","DOI":"10.1038\/s41598-020-69007-w","article-title":"Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature","volume":"10","author":"Palli","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104271_bib0061","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0893-6080(05)80023-1","volume":"5","year":"1992","journal-title":"Neural Netw"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0062","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1018046112532","article-title":"Stacked regressions","volume":"24","author":"Breiman","year":"1996","journal-title":"Mach Learn"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0063","article-title":"Super learner","volume":"6","author":"van der Laan","year":"2007","journal-title":"Stat Appl Genet Mol"},{"key":"10.1016\/j.ebiom.2022.104271_bib0064","series-title":"Targeted Learning. Springer Series in Statistics","article-title":"Super learning","author":"Polley","year":"2011"},{"key":"10.1016\/j.ebiom.2022.104271_bib0065","series-title":"Unified Cross-Validation Methodology for Selection Among Estimators and a General Cross-Validated Adaptive Epsilon-Net Estimator: Finite Sample Oracle Inequalities and Examples","author":"Van Der Laan","year":"2003"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104271_bib0066","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1524\/stnd.2006.24.3.351","article-title":"Oracle inequalities for multi-fold cross validation","volume":"24","author":"Van der Vaart","year":"2006","journal-title":"Stat Decis"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104271_bib0067","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0068","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the Lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J Roy Stat Soc B Met"},{"key":"10.1016\/j.ebiom.2022.104271_bib0069","doi-asserted-by":"crossref","unstructured":"Hastie TJ, Tibshirani R. Generalized Additive Models. 1st ed. Chapman and Hall\/CRC. ISBN 9780412343902 1990.","DOI":"10.1214\/ss\/1177013604"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0070","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1214\/15-EJS1035","article-title":"Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates","volume":"9","author":"LeDell","year":"2015","journal-title":"Electron J Statist"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104271_bib0071","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ebiom.2022.104271_bib0072","series-title":"Targeted Learning in Data Science: Causal Inference for Complex Longitudinal Studies","article-title":"Chapter 9: Data-adaptive target parameters","author":"Hubbard","year":"2018"},{"key":"10.1016\/j.ebiom.2022.104271_bib0073","series-title":"Targeted Learning: Causal Inference for Observational and Experimental Data","author":"van der Laan","year":"2011"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0074","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.ebiom.2022.104271_bib0075","first-page":"1","article-title":"A general framework for inference on algorithm-agnostic variable importance","author":"Williamson","year":"2021","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ebiom.2022.104271_bib0076","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1038\/srep06223","article-title":"Body height affects the strength of immune response in young men, but not young women","volume":"4","author":"Krams","year":"2014","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0077","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/emph\/eoaa017","article-title":"Evidence for height and immune function trade-offs among preadolescents in a high pathogen population","volume":"2020","author":"Garcia","year":"2020","journal-title":"Evol Med Public Health"},{"issue":"1859","key":"10.1016\/j.ebiom.2022.104271_bib0078","article-title":"Body height and immune efficacy: testing body stature as a signal of biological quality","volume":"284","author":"Pawlowski","year":"2017","journal-title":"Proc Biol Sci"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104271_bib0079","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ajh.24438","article-title":"Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses","volume":"91","author":"Balandya","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ebiom.2022.104271_bib0080","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3389\/fimmu.2020.01313","article-title":"Iron deficiency anemia at time of vaccination predicts decreased vaccine response and iron supplementation at time of vaccination increases humoral vaccine response: a birth cohort study and a randomized trial follow-up study in Kenyan Infants","volume":"11","author":"Stoffel","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104271_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(21)00201-5","article-title":"Vaccine efficacy and iron deficiency: an intertwined pair?","volume":"8","author":"Drakesmith","year":"2021","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104271_bib0082","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar3542","article-title":"Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor","volume":"13","author":"Kobie","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104271_bib0083","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1136\/annrheumdis-2016-210509","article-title":"H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production","volume":"76","author":"Brauner","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104271_bib0084","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.41937","article-title":"Evaluation of immune response and disease status in systemic lupus erythematosus patients following SARS-CoV-2 vaccination","volume":"74","author":"Izmirly","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13073-018-0568-8","article-title":"Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines","volume":"10","author":"Scepanovic","year":"2018","journal-title":"Genome Med"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104271_bib0086","doi-asserted-by":"crossref","first-page":"e22223","DOI":"10.1096\/fj.202101492R","article-title":"Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccination","volume":"36","author":"Shapira","year":"2022","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104271_bib0087","doi-asserted-by":"crossref","first-page":"63","DOI":"10.33160\/yam.2022.02.012","article-title":"Predictive model for adverse events and immune response based on the production of antibodies after the second-dose of the BNT162b2 mRNA vaccine","volume":"65","author":"Okada","year":"2022","journal-title":"Yonago Acta Med"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104271_bib0088","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12326","article-title":"How sex and age affect immune responses, susceptibility to infections, and response to vaccination","volume":"14","author":"Giefing-Kroll","year":"2015","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104271_bib0089","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.qai.0000222289.97825.35","article-title":"HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia","volume":"42","author":"Nguyen","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"18","key":"10.1016\/j.ebiom.2022.104271_bib0090","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1097\/00002030-199912240-00004","article-title":"The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed people","volume":"13","author":"Brown","year":"1999","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104271_bib0091","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/QAD.0b013e32835fac08","article-title":"HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein","volume":"27","author":"Carrillo","year":"2013","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104271_bib0092","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/aid.2010.0169","article-title":"Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women","volume":"27","author":"Mestecky","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104271_bib0093","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1084\/jem.20110363","article-title":"Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated","volume":"208","author":"Liao","year":"2011","journal-title":"J Exp Med"},{"issue":"6249","key":"10.1016\/j.ebiom.2022.104271_bib0094","doi-asserted-by":"crossref","first-page":"aab1253","DOI":"10.1126\/science.aab1253","article-title":"HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies","volume":"349","author":"Williams","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104271_bib0095","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.celrep.2019.03.032","article-title":"HIV-1 envelope recognition by polyreactive and cross-reactive intestinal B cells","volume":"27","author":"Planchais","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2022.104271_bib0096","doi-asserted-by":"crossref","unstructured":"Fourati S, Tomalin L, Mul\u00e8 M, et al. An innate immune activation state prior to vaccination predicts responsiveness to multiple vaccines. bioRxiv. 2021 [Preprint]. https:\/\/doi.org\/10.1101\/2021.09.26.461847. Access date: 8 Jul, 2022.","DOI":"10.1101\/2021.09.26.461847"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104271_bib0097","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1541-0420.2006.00569.x","article-title":"Augmented designs to assess immune response in vaccine trials","volume":"62","author":"Follmann","year":"2006","journal-title":"Biometrics"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:34:57Z","timestamp":1778873697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422004534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":97,"alternative-id":["S2352396422004534"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104271","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104271"}}